Search company, investor...


Founded Year



Incubator/Accelerator | Alive

About aiNET

aiNET leverages artificial intelligence and large-scale networks to help pharmaceutical industries and biotechs discover biologics from next-generation sequencing data. im2unity, an aiNET product, is a digital immunity application to check health, diagnose diseases early and follow disease progression, enabling to adjust treatment to personal patient journeys. The company was founded in 2017 and is founded in 2017 and is based in Basel, Switzerland.

Headquarters Location

Lichtstrasse 35

Basel, 4056,


Missing: aiNET's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: aiNET's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

aiNET Frequently Asked Questions (FAQ)

  • When was aiNET founded?

    aiNET was founded in 2017.

  • Where is aiNET's headquarters?

    aiNET's headquarters is located at Lichtstrasse 35, Basel.

  • What is aiNET's latest funding round?

    aiNET's latest funding round is Incubator/Accelerator.

  • Who are the investors of aiNET?

    Investors of aiNET include DayOne Accelerator and ETH Zurich.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.